ELI LILLY AND COMPANY

LYUMJEV U-100

Manufacturer:

ELI LILLY AND COMPANY

Lyumjev U-100 HCPCS:

J1813

HCPCS Code Descriptor:

Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units

Category:

J Code

Lyumjev U-100 NDCs:

00002-7728-01

Primary Type:

Insulin

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Lyumjev U-100:

LYUMJEV U-100 is a Insulin drug manufactured by ELI LILLY AND COMPANY and administered via the Injection route of administration. The J Code: J1813 is aligned to the drug LYUMJEV U-100.

ACCESS PRICING AND MORE BY REGISTERING

J1813 Added Date:

July 1, 2023

J1813 Effective Date:

July 1, 2023

J1813 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Lyumjev U-100 billing and coding information.
Lyumjev U-100 patient assistance information can be found through The Lilly Insulin Value Program at the URL: https://www.lyumjev.com/hcp/savings
LYUMJEV U-100 prescribing information can be found at the link below:
Information regarding LYUMJEV U-100’s side effects can be found at MedlinePlus